AAAAAA
Results:
1-20
|
Results: 20
Authors:
Ukkola, O
Erkkila, PH
Savolainen, MJ
Kesaniemi, YA
Citation: O. Ukkola et al., Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus, J INTERN M, 249(5), 2001, pp. 451-459
Authors:
Shukla, SD
Sun, GY
Wood, WG
Savolainen, MJ
Alling, C
Hoek, JB
Citation: Sd. Shukla et al., Ethanol and lipid metabolic signaling, ALC CLIN EX, 25(5), 2001, pp. 33S-39S
Authors:
Ribot, J
Rantala, M
Kesaniemi, YA
Palou, A
Savolainen, MJ
Citation: J. Ribot et al., Weight loss reduces expression of SREBP1c/ADD1 and PPAR gamma 2 in adiposetissue of obese women, PFLUG ARCH, 441(4), 2001, pp. 498-505
Authors:
Yli-Jokipii, K
Kallio, H
Schwab, U
Mykkanen, H
Kurvinen, JP
Savolainen, MJ
Tahvonen, R
Citation: K. Yli-jokipii et al., Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response, J LIPID RES, 42(10), 2001, pp. 1618-1625
Authors:
Kakko, S
Tamminen, M
Paivansalo, M
Kauma, H
Rantala, AO
Lilja, M
Reunanen, A
Kesaniemi, YA
Savolainen, MJ
Citation: S. Kakko et al., Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness, EUR J CL IN, 31(7), 2001, pp. 593-602
Authors:
Karjalainen, A
Heikkinen, J
Savolainen, MJ
Backstrom, AC
Kesaniemi, YA
Citation: A. Karjalainen et al., Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy, ART THROM V, 20(4), 2000, pp. 1101-1106
Authors:
Rantala, AO
Lilja, M
Kauma, H
Savolainen, MJ
Reunanen, A
Kesaniemi, YA
Citation: Ao. Rantala et al., Gamma-glutamyl transpeptidase and the metabolic syndrome, J INTERN M, 248(3), 2000, pp. 230-238
Authors:
Silaste, ML
Junes, R
Rantala, AO
Kauma, H
Lilja, M
Savolainen, MJ
Reunanen, A
Kesaniemi, YA
Citation: Ml. Silaste et al., Dietary and other non-pharmacological treatments in patients with drug-treated hypertension and control subjects, J INTERN M, 247(3), 2000, pp. 318-324
Authors:
Niemi, M
Kervinen, K
Kiviniemi, H
Lukkarinen, O
Kyllonen, AP
Apaja-Sarkkinen, M
Savolainen, MJ
Kairaluoma, MI
Kesaniemi, YA
Citation: M. Niemi et al., Apolipoprotein E phenotype, cholesterol and breast and prostate cancer, J EPIDEM C, 54(12), 2000, pp. 938-939
Authors:
Paivansalo, MJ
Merikanto, J
Jerkkola, T
Savolainen, MJ
Rantala, AO
Kauma, H
Lilja, M
Reunanen, A
Kesaniemi, A
Suramo, I
Citation: Mj. Paivansalo et al., Effect of hypertension and risk factors on diameters of abdominal aorta and common iliac and femoral arteries in middle-aged hypertensive and controlsubjects - A cross-sectional systematic study with duplex ultrasound, ATHEROSCLER, 153(1), 2000, pp. 99-106
Authors:
Karjalainen, A
Heikkinen, J
Savolainen, MJ
Backstrom, AC
Kesaniemi, YA
Citation: A. Karjalainen et al., Regulation of plasma low density lipoprotein levels in postmenopausal women, ATHEROSCLER, 151(2), 2000, pp. 559-566
Authors:
Paassilta, M
Karjalainen, A
Kervinen, K
Savolainen, MJ
Heikkinen, J
Backstrom, AC
Kesaniemi, YA
Citation: M. Paassilta et al., Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a)levels, ATHEROSCLER, 149(1), 2000, pp. 157-162
Authors:
Kakko, S
Tamminen, M
Paivansalo, M
Kauma, H
Rantala, AO
Lilja, M
Reunanen, A
Kesaniemi, YA
Savolainen, MJ
Citation: S. Kakko et al., Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men, EUR J CL IN, 30(1), 2000, pp. 18-25
Authors:
Rantala, M
Rantala, TT
Savolainen, MJ
Friedlander, Y
Kesaniemi, YA
Citation: M. Rantala et al., Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of therole of genetic variation in responsiveness to diet, AM J CLIN N, 71(3), 2000, pp. 713-724
Authors:
Rantala, AO
Kauma, H
Lilja, M
Savolainen, MJ
Reunanen, A
Kesaniemi, YA
Citation: Ao. Rantala et al., Prevalence of the metabolic syndrome in drug-treated hypertensive patientsand control subjects, J INTERN M, 245(2), 1999, pp. 163-174
Authors:
Kauma, H
Savolainen, MJ
Kesaniemi, YA
Citation: H. Kauma et al., Apolipoprotein E, alcohol, and blood pressure: Reply to Puddey et al, AM J HYPERT, 12(9), 1999, pp. 949-950
Authors:
Korhonen, T
Hannuksela, ML
Seppanen, S
Kervinen, K
Kesaniemi, YA
Savolainen, MJ
Citation: T. Korhonen et al., The effect of the apolipoprotein E phenotype on cholesteryl ester transferprotein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment, EUR J CL PH, 54(12), 1999, pp. 903-910
Authors:
Korhonen, T
Savolainen, MJ
Kesaniemi, YA
Citation: T. Korhonen et al., Variation of apolipoprotein B as a possible cause of decreased low densitylipoprotein clearance and hypercholesterolemia, ATHEROSCLER, 146(1), 1999, pp. 1-10
Authors:
Niemi, M
Kervinen, K
Rantala, A
Kauma, H
Paivansalo, M
Savolainen, MJ
Lilja, M
Kesaniemi, YA
Citation: M. Niemi et al., The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects, GUT, 44(4), 1999, pp. 557-562
Authors:
Gudnason, V
Kakko, S
Nicaud, V
Savolainen, MJ
Kesaniemi, YA
Tahvanainen, E
Humphries, S
Citation: V. Gudnason et al., Cholesteryl ester transfer protein gene effect on CETP activity and plasmahigh-density lipoprotein in European populations, EUR J CL IN, 29(2), 1999, pp. 116-128
Risultati:
1-20
|